Literature DB >> 20718920

Use of 3D imaging and awareness of GEC-ESTRO recommendations for cervix cancer brachytherapy throughout Australia and New Zealand.

S van Dyk1, D Byram, D Bernshaw.   

Abstract

INTRODUCTION: A 2005 survey of practices indicated limited use of three-dimensional (3D) imaging modalities and planning methods in cervix cancer brachytherapy in Australia and New Zealand. However, advancing technologies and published recommendations are influencing change. This survey aims to identify both changes in practice and awareness and uptake of Groupe European de Curietherapie of the European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) recommendations.
METHODS: A survey was emailed to all radiotherapy departments with brachytherapy facilities. Twenty departments practise brachytherapy for cancer of the cervix. The survey consisted of five questions enquiring about use and type of 3D imaging; rate of reimaging and replanning; and contouring, prescribing and reporting practices.
RESULTS: A 100% response rate was obtained. Sixty-five per cent of departments use 3D CT imaging to plan brachytherapy insertions. Thirty per cent of departments use two-dimensional (2D) x-rays. Four departments (20%) use a combination of imaging modalities including CT, ultrasound and MRI. Sixty-five per cent of departments reimage and replan for each insertion. Four departments (20%) contour, prescribe dose and report treatment according to GEC-ESTRO recommendations.
CONCLUSIONS: There has been a marked increase in the use of 3D imaging and awareness of GEC-ESTRO recommendations. Implementation and reporting of image-based gynaecological brachytherapy is strongly dependent on local resources and infrastructure.

Entities:  

Mesh:

Year:  2010        PMID: 20718920     DOI: 10.1111/j.1754-9485.2010.02185.x

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  8 in total

1.  Preliminary results of a new workflow for MRI/CT-based image-guided brachytherapy in cervical carcinoma.

Authors:  Miho Watanabe Nemoto; Yuma Iwai; Gentaro Togasaki; Marie Kurokawa; Rintarou Harada; Hiroki Kobayashi; Takashi Uno
Journal:  Jpn J Radiol       Date:  2017-10-16       Impact factor: 2.374

Review 2.  American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.

Authors:  Jyoti Mayadev; Akila Viswanathan; Yu Liu; Chin-Shang Li; Kevin Albuquerque; Antonio L Damato; Sushil Beriwal; Beth Erickson
Journal:  Brachytherapy       Date:  2017 Jan - Feb       Impact factor: 2.362

3.  Will MR image-guided brachytherapy be a standard of care for cervical cancer in future? An Indian perspective.

Authors:  D D Deshpande
Journal:  J Med Phys       Date:  2012-01

4.  Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients.

Authors:  Tatsuya Ohno; Masaru Wakatsuki; Takafumi Toita; Yuko Kaneyasu; Ken Yoshida; Shingo Kato; Noriko Ii; Sunao Tokumaru; Hitoshi Ikushima; Takashi Uno; Shin-Ei Noda; Tomoko Kazumoto; Yoko Harima
Journal:  J Radiat Res       Date:  2017-05-01       Impact factor: 2.724

5.  Preliminary survey of 3D image-guided brachytherapy for cervical cancer at representative hospitals in Asian countries.

Authors:  Noriyuki Okonogi; Masaru Wakatsuki; Hideyuki Mizuno; Shigekazu Fukuda; Jianping Cao; Henry Kodrat; Fen Nee Lau; Miriam Joy Calaguas; Rey H de Los Reyes; Yaowalak Chansilpa; A F M Kamal Uddin; Tasbolat Adylkhanov; Chul-Koo Cho; Uranchimeg Tsegmed; Nguyen Cong Hoang; Tatsuya Ohno; Takashi Nakano; Shingo Kato
Journal:  J Radiat Res       Date:  2020-07-06       Impact factor: 2.724

6.  A prospective observational study with dose volume parameters predicting rectosigmoidoscopic findings and late rectosigmoid bleeding in patients with uterine cervical cancer treated by definitive radiotherapy.

Authors:  Tae Hyun Kim; Joo-Young Kim; Dae Kyung Sohn; Yeon-Joo Kim; Yoon-Seok Lee; Sung Ho Moon; Sang Soo Kim; Dae Yong Kim
Journal:  Radiat Oncol       Date:  2013-01-31       Impact factor: 3.481

7.  A questionnaire-based survey on 3D image-guided brachytherapy for cervical cancer in Japan: advances and obstacles.

Authors:  Tatsuya Ohno; Takafumi Toita; Kayoko Tsujino; Nobue Uchida; Kazuo Hatano; Tetsuo Nishimura; Satoshi Ishikura
Journal:  J Radiat Res       Date:  2015-08-11       Impact factor: 2.724

8.  Standard Chemoradiation and Conventional Brachytherapy for Locally Advanced Cervical Cancer: Is It Still Applicable in the Era of Magnetic Resonance-Based Brachytherapy?

Authors:  Prachi Mittal; Supriya Chopra; Sidharth Pant; Umesh Mahantshetty; Reena Engineer; Jaya Ghosh; Sudeep Gupta; Yogesh Ghadi; Siji Menachery; Jamema Swamidas; Lavanya Gurram; Shyam Kishore Shrivastava
Journal:  J Glob Oncol       Date:  2018-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.